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Venous ulcers continue to cause problems for patients and health care systems. These are painful and unpleasant for the patient
and expensive for health care providers to treat. This brief review highlights effective methods of management. There is level
1 evidence of the efficacy of compression (bandaging or stockings) in healing ulcers as well as maintaining healing. Patients
with superficial saphenous reflux, with or without perforating and deep vein incompetence, benefit from superficial venous
surgery. This does not speed ulcer healing but is effective at preventing recurrence after healing with compression. Minimally
invasive methods of managing incompetence of superficial saphenous trunks, including endovenous laser ablation, radiofre-
quency ablation, and foam sclerotherapy are probably also effective in treating patients with venous leg ulcers. Perforating vein
ligation is commonly combined with superficial venous surgery for leg ulcer patients, but no systematic data are available to
define the role of this treatment. Some centers use deep vein reconstruction to restore competence to deep vein valves.
Insufficient data have been published to allow any general recommendation to be made for this treatment. A limited number
of drugs have efficacy in promoting leg ulcer healing. Theymay be used in combinationwith compression treatment in patients
with ulcers refractory to othermethods ofmanagement.Noparticular ulcer dressing has been shown to be effective in speeding
ulcer healing. (J Vasc Surg 2009;49:804-8.)Venous ulcers have been treated by bandaging and
topical applications for thousands of years. More recently,
surgical intervention and drug treatments have been added
to these ancient methods. So what is the most appropriate
way of managing a venous leg ulcer? It is essential to
understand the pathologic mechanisms causing the ulcer,
because leg ulceration may be the result of venous disease,
arterial disease, diabetes, neuropathies, vasculitis, infection,
and neoplasm, to mention only the most frequent. Com-
binations of these occur commonly, increasing the difficul-
ties for the clinician. This subject is considered in detail in
the Handbook of the American Venous Forum.1 Duplex
ultrasound imaging is a crucial element in diagnosis, and a
consensus statement of methods and interpretation of data
from such investigations has been published.2,3
RESULTS OF DATA SEARCH
From a literature search in PubMed and the Cochrane
Database, studies were selected evaluating the effect of
three classes of therapy for venous ulcer: compression,
surgical, and drug treatment.
Compression treatment. Bandaging of leg ulcers is
an ancient treatment that has been used since 3500 BC. In
recent years, studies have confirmed that compression ban-
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804daging and the application of stockings leads to healing of
venous leg ulcers. A detailed review of the efficacy of
compression treatments in venous disease has been pub-
lished by Partsch et al.4 They conclude that compression
stockings, particularly those of 20 to 30 mmHg or greater,
and compression bandaging lead to reductions in edema,
venous diameter, and venous reflux and to improvement in
the function of the calf muscle pump.
There is level 1A evidence that compression bandaging
promotes the healing of venous ulcers and level 1B evi-
dence for strong compression hosiery (30-40 mm Hg).
There is also level 1A evidence that compression hosiery
(30-40 mm Hg) prevents recurrence of ulceration after
healing. Therefore, the first-line treatment for venous leg
ulcers should be compression bandaging or strong hosiery
where this is not contraindicated; for example, in patients
with clinically significant peripheral artery disease. Once leg
ulceration has healed, strong compression stockings should
be prescribed to maintain healing. Intermittent pneumatic
compression has also been used for the management of leg
ulcers, but the evidence for this is weak, confined to limited
clinical series.5 Studies detailing compression treatment are
summarized in Table I.
Surgical treatment. Surgical treatment for venous ul-
cers has been used for many years. Stripping of the saphe-
nous vein was described 100 years ago both by Keller6 and
by Babcock,7 who used slightly different techniques to strip
the vein from groin to ankle.More recently, stripping of the
great saphenous vein below the knee has been abandoned
to avoid the risks of injury to the saphenous nerve. The
Oesch pin-stripping technique is common,8 but several
other methods are also used. Open perforating vein surgery
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Study
(first author) Study design Population/procedure
No. of patients/studies
cited Main conclusions
Partsch4 Systematic review Compression stockings,
bandages, intermittent
pneumatic compression.
CEAP: C1-C6
174 articles, 2548 patients In C6 patients: Compression bandaging
effective (level 1A), compression
hosiery effective (level 1B). In C5
patients: Compression hosiery
prevents recurrence of ulcers
Nelson5 Systematic review Leg ulcers, intermittent
pneumatic compression, and
continuous compression
techniques. CEAP: C6
7 RCTs, 367 patients Intermittent pneumatic compression
may improve healing vs no
compression; insufficient evidence to
draw conclusions on comparison
with bandaging and compression
stockingsRCT, Randomized controlled trial.Table II. Surgical treatment—the outcome of commonly used techniques
Study
(first author)
Study
design Population/procedure No. of patients/studies cited Results/main conclusions
Barwell12 RCT Patients with leg ulcers or recently
healed ulcers; randomized to
compression or compression
plus superficial saphenous
surgery. CEAP: C5 and C6
1418 patients screened, 500
randomized
Superficial saphenous surgery did not
influence ulcer-healing rate, but
reduced the 12-mon recurrence
rate from 28% to 12%.
Gloviczki1 Treatment
registry
Patients with healed or open
venous ulcers; SEPS alone or
combined with superficial
saphenous surgery (71% of
cases). CEAP: C5 and C6
146 patients Ulcer healing: 88% at 12 months.
Cumulative ulcer recurrence: 16%
at 1 y; 28% at 2 y. Symptoms and
signs of venous disease improved
by SEPS combined with superficial
saphenous surgery.
Iafrati14 Clinical
series
Patients with healed or open
venous ulcers. SEPS alone
combined with superficial
saphenous surgery (56% of
limbs). CEAP: C5 and C6
45 patients (51 limbs) Ulcer healing: 74% at 6 mon.
Recurrence after healing: 13% at
5 y. Combined SEPS and
superficial saphenous surgery is
useful in the management of
severe venous disease.
Hardy17 Systematic
review
Patients with severe venous
disease undergoing ligation of
superficial incompetent veins
and deep vein valvuloplasty
(external) or ligation of
superficial veins alone. CEAP:
C4-C5
2 RCTs, 112 patients Moderate improvements in clinical
symptoms and reductions in
ambulatory venous pressures
reported. Clinical trials too small
to recommend surgical
valvuloplasty to a wider group of
patients.
Masuda15 Clinical
series
Patients with severe venous
disease managed by deep vein
valvuloplasty (various
techniques). CEAP: C4-C6
48 patients (51 limbs) Good outcome observed in primary
non-thrombotic deep vein
incompetence (no or minor
venous disease symptoms) in 73%
of limbs vs 43% of post-thrombotic
limbs.
Perrin16 Clinical
series
Patients with severe venous
disease managed by
valvuloplasty (n  85),
transposition (n  18),
transplantation (n  32), or
Psathakis’ technique II (n  9).
CEAP: C3-C6
133 patients (144 limbs) DUS showed that valvular
competence was restored in 79% of
limbs (valvuloplasty), 71% (valve
transposition), and 48% (valve
transplantation). Leg ulcers
remained healed in 50% of post-
thrombotic limbs and 75% of limbs
with primary valvular
incompetence. Deep vein
reconstruction most appropriate in
latter group.DUS, Duplex ultrasound imaging; RCT, randomized controlled trial; SEPS, subfascial endoscopic surgery.
ascial
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wound-healing problems.9,10 In more recent years, subfas-
cial endoscopic surgery (SEPS), which carries less risk of
wound-healing problems, has been used to ligate incompe-
tent perforating vein.11
The role of saphenous stripping was investigated in the
Effect of Surgery and Compression on Healing and Recur-
rence (ESCHAR) study.12 This clinical trial randomized
500 patients from three hospitals to undergo treatment of
venous leg ulcers by compression alone or combined with
superficial saphenous surgery. After 24 weeks, ulcers had
healed in 65% of patients in both groups, but recurrent
ulceration occurred in 12% of the compression and surgery
group compared with 28% in the compression alone group.
Superficial venous surgery is effective at maintaining heal-
ing of venous ulcers and should be offered to patients even
in the presence of concomitant deep vein incompetence.
The role of perforating vein surgery for venous ulcers has
not been studied in such detail. The procedures originally
described by Linton and Cockett are not in common use.
SEPS has replaced these, but no detailed clinical trial has
established the role and value of this operation. The North
American SEPS Registry showed a cumulative healing rate of
88% at 1 year, although concomitant superficial venous sur-
gery was done in many patients.13 Ulcer recurrence in this
series was 16% at 1 year and 28% at 2 years, similar to that
Table III. New treatments for varicose veins, use in the m
Study
(first author) Study design Population/procedure
Viarengo18 RCT Patients with venous leg ulcers
were treated by compression
bandaging alone or ELA of
incompetent saphenous
trunks. CEAP: C6
Sharif19 Clinical series Patients with severe venous
disease managed by
endovenous laser ablation.
CEAP: C4-C6
Puggioni20 Clinical series Patients with moderate to
severe venous disease
managed by a combination
of ELA, RFA, and SEPS.
CEAP: C2-C6
Pascarella21 Clinical series Patients with severe venous
disease: C4, 7 limbs; C5, 18
limbs; C6, 35 limbs. Three
treatment groups were
involved: compression
alone, foam sclerotherapy
after failed compression,
and foam sclerotherapy.
Van den Bos22 Meta-analysis Patients with venous disease
managed by surgery, RLA,
RFA, and foam
sclerotherapy. Main
outcome measure: ablation
of saphenous trunk on US
imaging. CEAP: C2-C6
ELA, Endovenous laser ablation; RFA, radiofrequency ablation; SEPS, subfreported in the ESCHAR study. In another small series, a 13%ulcer recurrence rate was reported at 5 years after a combina-
tionof SEPS and superficial venous surgery.14The precise role
of perforating vein surgery is not well defined at present, but is
widely used in combination with superficial venous surgery
where incompetent calf perforating veins are identified on
duplex ultrasound imaging.
A number of reports have been published of deep vein
surgery to address deep vein incompetence that results in
symptomatic venous disease.15,16 A Cochrane Review of
available controlled studies is available.17 The authors con-
clude that although valvuloplasty may achieve moderate
and sustained clinical improvement, the available clinical
trials provide insufficient data at present to make more
general recommendations. At present, this treatment re-
mains in limited clinical use in specialized centers. Surgical
treatment is summarized in Table II.
New methods of treating varicose veins have gained
widespread support in many countries and include en-
dovenous laser and radiofrequency ablation as well as
ultrasound-guided foam sclerotherapy. Limited clinical se-
ries of treatment of saphenous incompetence in patients
with leg ulcers have been reported using endovenous laser
ablation,18,19 radiofrequency ablation,20 and foam sclero-
therapy21 (Table III). No clinical trial has been published
comparing these treatments with surgical intervention in
patients with leg ulcers. A recently published meta-analysis
ement of venous ulcers
of patients/studies
cited Main conclusions
tients randomized 12 mon post-treatment: 82% of ELA treated
patients and 24% of the compression
group had healed ulcers. ELA of
incompetent saphenous trunks promotes
venous ulcer healing.
tients (23 limbs) The cumulative healing rates: 3 mon, 87%;
12 mon, 100%; 22 mon, 95%. ELA is
effective in the treatment and prevention
of venous ulcers.
tients (130 limbs) The treated saphenous trunk was occluded
in 94% of patients, with few adverse
events. Clinical outcome not reported.
tients (60 limbs) All patients in the compression alone group
and the failed compression and foam
sclerotherapy groups had healed ulcers in
6 wks. With foam sclerotherapy alone, all
11 ulcers healed within 4 weeks. The
combination of compression treatment
and foam sclerotherapy is effective in
managing severe venous disease.
tudies, ? patients
,320 limbs)
At a mean follow-up of 32 months, the
saphenous obliteration rate was surgical
stripping, 78%; foam sclerotherapy, 77%;
RFA, 84%; and ELA, 94%. Minimally
invasive treatment for varicose veins is at
least as effective as surgery.
endoscopic surgery; US, ultrasound.anag
No.
52 pa
20 pa
92 pa
44 pa
119 s
(12suggests that endovenous treatments are as effective as
T, ran
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petence,22 so until more definite evidence is available, the
conclusions of the ESCHAR study likely apply to these
methods as well. Endovenous treatments are less invasive
than conventional surgery, which may be advantageous in
more elderly patients who are affected by leg ulcers.
Drug treatment. Awide range of drugs have been used
to help heal venous leg ulcers; however, only a very limited
number have presented evidence of efficacy (Table IV).23-27
Pentoxifylline, a methylxanthine that has been used in the
management of intermittent claudication, has been the sub-
ject of a Cochrane Review in the context of its use in the
management of venous ulceration.23 The authors identified
11 studies and concluded that this drug is effective in promot-
ing leg ulcer healingwhenused in combinationwith compres-
sion treatment. A further meta-analysis was published of four
controlled trials that studied the use of micronized purified
flavonoid fraction (MPFF) combined with compression treat-
ment.24 The mean healing time was 16 weeks in patients
treated with MPFF plus compression compared with 21
Table IV. Drug treatment and dressings in the manageme
Study
(first author) Study design Population/procedure
Jull23 Meta-analysis Patients with venous ulcers
managed by
compression and
placebo or oral
pentoxifylline. CEAP:
C6
Coleridge-
Smith24
Meta-analysis Patients with venous ulcers
managed by
compression and
placebo or MPFF taken
orally. CEAP: C6
Martinez25 Meta-analysis Patients with any venous
disease treated with
phlebotonic drugs.
CEAP: C1-C6
Ferrara26 RCT Patients with venous ulcers
were randomized to a
daily intravenous
infusion of iloprost or
saline for 3 weeks.
CEAP: C6
Palfreyman27 Meta-analysis Patients with venous leg
ulcers managed with
various dressing types.
CEAP: C6
CI, Confidence interval; MPFF, micronized purified flavonoid fraction; RCweeks in patients with compression alone.A wider review of the efficacy of phlebotropic drugs has
been published in a further Cochrane Review.25 The au-
thors conclude that evidence is sufficient to show that
phlebotonic drugs are generally effective in reducing edema
in chronic venous disease; however, they could find insuf-
ficient evidence to support global use of these drugs. Pa-
tients in a clinical study received a daily infusion of saline or
iloprost for 3 weeks combined with conventional treatment
for varicose veins.26 After 90 days, ulcers had healed in all of
the iloprost-treated patients, but in only half of the saline-
treated patients. By 150 days, ulcers had healed in 85% of
the saline group. No further study has been published.
Topical applications and the type of dressing used to
manage leg ulcers have not been shown to influence ulcer
healing.27
CONCLUSIONS
The first-line management of patients with confirmed
venous ulcers is compression treatment with bandaging
systems or strong compression hosiery, unless contraindi-
f venous disease
No. of patients/studies
cited Results/main conclusions
12 trials, 864 patients Pentoxifylline is more effective than
placebo in terms of complete
ulcer healing or significant
improvement (RR, 1.70; 95% CI,
1.30-2.24). Pentoxifylline is an
effective adjunct to compression
bandaging for treating venous
ulcers.
5 trials, 723 patients The chance of an ulcer healing 6
months was 32% better in
patients treated with adjunctive
MPFF than in those managed by
conventional therapy alone
(RRR, 32%; CI, 3%-70%). MPFF
treatment accelerates venous
ulcer healing.
44 trials, 4413 patients Some evidence of efficacy in the
management of edema, but not
enough evidence exists globally
to support the efficacy of
phlebotonics for chronic venous
insufficiency.
98 patients
randomized
All ulcers in the iloprost group
healed 90 d; 84% of ulcers
healed by 150 days in the saline
(control) group. Iloprost
infusions reduce length to
venous ulcer healing.
42 RCTs, 3001
patients
The type of dressing applied
beneath compression has not
been shown to affect ulcer
healing. No significant difference
observed in healing rates
between hydrocolloid dressings
and simple, low-adherent
dressings.
domized controlled trial; RR, relative risk; RRR, relative risk ratio.nt ocated. Surgical treatment of superficial saphenous trunks
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subsequent recurrence and should be offered to leg ulcer
patients in whom superficial venous incompetence is
present. No direct evidence of efficacy for the new en-
dovenous techniques is available except from small clinical
series, which report promising results. It is reasonable to
conclude that saphenous ablation achieved by any of the
endovenous methods will lead to similar outcomes as sur-
gical treatment.
Perforating vein ligation using SEPS is performed in
some centers, but much of the available data are from
clinical series in which concomitant saphenous vein surgery
has been performed. The precise role of this treatment
remains undefined. Surgical reconstruction of deep vein
valves is used in a small number of centers, but insufficient
data are available to recommend this for general use.
Efficacy of two drugs, pentoxifylline and MPFF, has
been found in meta-analyses. The use of these could be
considered in patients with ulcers where compression and
superficial vein ablation techniques have been ineffective.
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